Monika Szymonek

S. Artwińskiego Str. 3
Kielce, SK 25734, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

A Significance of Concomitant BRAFV600E and TERT Mutations in Polish Patients with Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Based on 430 Cases.

A Significance of Concomitant BRAFV600E and TERT Mutations in Polish Patients with Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Based on 430 Cases.

Journal: Thyroid : official journal of the American Thyroid Association
Published: August 11, 2022

Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?

Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?

Journal: Journal of clinical medicine
Published: May 13, 2021

Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?

Does the TT Variant of the rs966423 Polymorphism in DIRC3 Affect the Stage and Clinical Course of Papillary Thyroid Cancer?

Journal: Cancers
Published: January 19, 2020

The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.

The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.

Journal: PloS one
Published: April 07, 2018

Delayed risk stratification system in pT1aN0/Nx DTC patients treated without radioactive iodine.

Delayed risk stratification system in pT1aN0/Nx DTC patients treated without radioactive iodine.

Journal: Endocrine connections
Published: July 24, 2017

Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma.

Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma.

Journal: Oncotarget
Published: May 17, 2017

Response to therapy of papillary thyroid cancer of known BRAF status.

Response to therapy of papillary thyroid cancer of known BRAF status.

Journal: Clinical endocrinology
Published: February 19, 2017

The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence.

The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence.

Journal: PloS one
Published: January 06, 2016
Showing 1-8 of 8

Last Updated: 09/26/2026